David R. Bauer
Lawyers
Filters
Ionis Pharmaceuticals $770 million convertible senior notes offering
We advised the representatives of the initial purchasers on the offering
GRAIL $300 million at-the-market offering
We advised the sales agents on the offering
Novanta $632.5 million tangible equity units offering
We advised the representatives of the several underwriters on the offering
Bristol Myers Squibb €5 billion notes offering
We advised the underwriters on Bristol Myers Squibb Ireland’s inaugural euro issuance
Inventiva $100 million at-the-market offering
The American depository shares are listed on Nasdaq
Bloom Energy $2.5 billion convertible senior notes offering
The 0% convertible senior notes are due 2030
Cybin $175 million registered direct offering
The common shares are dual-listed on the NYSE American and Cboe Canada
Novo Nordisk proposed $9.1 billion acquisition of Metsera
We are advising Novo Nordisk on the transaction
GSK exclusive license agreement with Empirico
We advised GSK on the transaction
RAPT Therapeutics $250 million follow-on offering
The shares are listed on the Nasdaq Global Market